JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 26 No. 1 68-71
© 1985 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelbaek, H.
Right arrow Articles by Fogh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelbaek, H.
Right arrow Articles by Fogh, J.

Technetium-99m Labeling of Polymorphonuclear Leukocytes: Preparation with Two Different Stannous Agents

Henning Kelbaek and Jan Fogh

Department of Clinical Physiology, Nuclear Medicine Department of Clinical Chemistry and Department of Medicine, Herlev University Hospital, Denmark

Correspondence: For reprints contact: Henning Kelbaek, MD, Dept. of Clinical Physiology and Nuclear Medicine, Herlev University Hospital, DK-2730 Herlev, Denmark.

ABSTRACT

A technique for in vitro labeling of human polymorphonuclear leukocytes with Tc-99m is described. Titration of stannous fluoride and stannous pyrophosphate concentrations for pretinning was performed, and optimal amounts of the stannous agents were added to polymorphonuclear leukocytes efficiently isolated from 100 ml of blood. Labeling with 10–15 mCi Tc-99m resulted, after three washings of cell suspensions, in yields of 1.6–4.8 mCi, corresponding to 20.5–33.5% of added tracer. Cell-bound activity in the final cell suspensions was 92.3% ± 1.9 of the added dose. Cell function was not impaired by the labeling technique. Sterility and exclusion of bacterial endotoxins in the final cell suspensions were demonstrated. The method may prove of diagnostic value in the isolation, labeling, and reinjection of autologous leukocytes for scintigraphic imaging of acute inflammatory lesions.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
D. Hommer, P. Andreasen, D. Rio, W. Williams, U. Ruttimann, R. Momenan, A. Zametkin, R. Rawlings, and M. Linnoila
Effects of m-Chlorophenylpiperazine on Regional Brain Glucose Utilization: A Positron Emission Tomographic Comparison of Alcoholic and Control Subjects
J. Neurosci., April 15, 1997; 17(8): 2796 - 2806.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1985 by the Society of Nuclear Medicine.